WYC-210

• CAT Number: I014908
• CAS Number: 2131803-93-3
• Molecular Formula: C₁₈H₁₆N₂O₃S
• Molecular Weight: 340.40
• Purity: ≥95%
• IUPAC Name: 2-[2-(4,4-dimethyl-1-oxo-2,3-dihydrothiochromen-6-yl)ethynyl]pyrimidine-5-carboxylic acid
• InChI: InChI=1S/C18H16N2O3S/c1-18(2)7-8-24(23)15-5-3-12(9-14(15)18)4-6-16-19-10-13(11-20-16)17(21)22/h3,5,9-11H,7-8H2,1-2H3,(H,21,22)
• InChIKey: NENFGFHRYIOMTM-UHFFFAOYSA-N
• SMILES: CC1(CCS(=O)C2=C1C=C(C=C2)C#CC3=NC=C(C=N3)C(=O)O)C

WYC-210（Cat No.:I014908）is a selective small molecule inhibitor that targets specific enzymes or signaling pathways involved in various diseases, particularly in the fields of oncology and inflammation. It has shown potential in preclinical studies for its ability to modulate cellular processes such as cell cycle progression, apoptosis, and immune response. WYC-210 is being explored as a potential therapeutic agent for cancers, including solid tumors, by disrupting tumor growth and enhancing immune system activity. However, further research and clinical trials are needed to evaluate its efficacy, safety, pharmacokinetics, and long-term therapeutic potential.

Reference

[1]. Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1.